| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-06 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |